Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063899
Chunk: 150

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 150
---
 business, financial condition and results of operations.

DiamiR recognizes that there are inherent risks associated with third-party relationships, which may adversely affect its business.

DiamiR expects to continue
to depend on third-party service providers for the foreseeable future, but DiamiR recognizes that there are inherent risks associated
with these third-party relationships. For example, its reputation may be harmed by allegations of wrong-doings or violations of regulations
by the third-party service providers. The security of its confidential and sensitive business information may be breached if the third-party
service providers do not exercise high standard of care to guard and protect the information that comes to their possession because of
the relationships with us. DiamiR does not have control over the amount of time and effort and level of care its third-party service providers
will devote to performing their responsibilities under DiamiRs agreements with them.

If DiamiR is unable to use or maintain its trademarks and trade names or build brand recognition in its markets of interest, its business may be adversely affected.

DiamiR’s US Federal
trademarks for the marks CogniMIR and DiamiR have been registered by the USPTO. If DiamiR does not maintain
any registrations granted by the USPTO, DiamiR may encounter difficulty in continuing to use or enforce such trademarks. DiamiR’s
trademarks or trade names may be challenged, infringed, circumvented, declared generic/descriptive or determined to be infringing on other
marks. As a means to enforce its trademark rights and prevent infringement/dilution, DiamiR may be required to file trademark claims against
third parties or initiate trademark opposition/cancellation proceedings. This can be expensive and time-consuming. In addition, a third
party could file trademark claims against the Company leading a court to decide that one or more of the Company’s trademarks is
not valid or unenforceable and enjoin the Company from further use of the same. If DiamiR is unable to use or maintain its company marks
for purposes of building brand name recognition by potential partners or customers or DiamiR is unable to establish brand recognition
based on those trademarks and trade names, then it may not be able to compete effectively, and DiamiR’s business may be adversely
affected.

DiamiR may be unable to develop new products and services or acquire products and services on favorable terms.

The molecular diagnostics
industry is characterized by ongoing technological developments and changing customer requirements. As such, DiamiR’s